Epidemiology of Diabetes
mellitus
Specific Learning Objectives
At the end of the class the student should be able to:
Enumerate the risk factors for Diabetes mellitus (DM)
Diagnose DM based on blood sugar values
List the preventive measures in accordance with the
levels of prevention
Enumerate the components of self-management in
PLAN
Definition and Classification of Diabetes
Burden of diabetes mellitus (Type 2)
Epidemiological determinants
Clinical features
Prevention and control
Summary
Definition
A metabolic disorder of multiple aetiology
characterized by chronic hyperglycaemia with
disturbances of carbohydrate, fat and protein
metabolism resulting from defects in insulin
secretion, insulin action or both
Classification
 Type 1 diabetes
Lack of insulin
Autoimmune
Usually children
Type 2 diabetes
Insulin resistance
Lifestyle factors
Usually adults
Gestational diabetes
Insulin resistance
During pregnancy
Risks to mother and child
Impaired Glucose tolerance (IGT)
Malnutrition Related Diabetes (MRDM)
Other Types
Hormonal
Drug Induced
Genetic
Prevalence of diabetes worldwide in 2000 (per 1000
inhabitants). World average was 28.23‰
no data
less than 7.5
7.5-15
15-22.5
22.5-30
30-37.5
37.5-45
45-52.5
52.5-60
60-67.5
67.5-75
75-82.5
more than 82.5
http://en.wikipedia.org/wiki/File:Diabetes_world_map_-_2000.svg
Worldwide Prevalence of Diabetes 2000-
2030
Diabetes Prevalence 2013
People with diabetes require at least two to three
times the health-care resources compared to people
who do not have
diabetes care may account for up to 15% of national
health care budgets
risk of tuberculosis is three times higher among
people with diabetes
http://www.diabetesatlas.org/across-the-globe.html
Proportion of Diabetes related deaths in people under
60 out of all dying due to diabetes
Age-standardized prevalence of diabetes in adults
aged 25+ years,
by WHO Region and World Bank income group, comparable estimates, 2008
Chapter 1 – Burden: mortality, morbidity and risk factors. http://www.who.int/diabetes/facts/en/
Estimated number of diabetic subjects in
India.
Epidemiology of type 2 diabetes: Indian scenario Indian J Med Res 125, March 2007, pp 217-230
Projected increase in diabetes - India
 Because of “Asian Indian Phenotype”
 unique clinical and biochemical
abnormalities in Indians
 increased insulin resistance, greater
abdominal adiposity
 higher waist circumference despite
lower BMI,
 lower adiponectin and higher high
sensitive C-reactive protein levels.
Recent population based studies showings the
prevalence of type 2 diabetes in different parts of India
Epidemiology of type 2 diabetes: Indian scenario Indian J Med Res 125, March 2007, pp 217-230
India vs world prevalence of diabetes
Indian Scenario
Prevalence – 8.6 %
66 million estimated cases
53% of these cases are undiagnosed
1/3rd of income spent on Diabetes in poorest
households
"Diabetes Capital of the World"
Source: Diabetes Atlas, International Diabetes Federation 6th edition
Secular trends in the prevalence of impaired glucose
tolerance (IGT) and diabetes at Chennai
Age wise prevalence of diabetes Chennai urban rural
epidemiology study (CURES) vs National Urban
Diabetes Survey (NUDS) [ref 39]
Haat09i1p1.pdf
Global Prevalence of DiabetesDIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004
Why This Scenario?
 primary driver - rapid epidemiological transition
 associated with changes in dietary patterns
 decreased physical activity
 as evident from the higher prevalence of diabetes in the urban
population
 prevalence of microvascular complications retinopathy and
nephropathy are comparatively lower in Indians,
 prevalence of premature coronary artery disease is much higher
in Indians compared to other ethnic groups.
Risk factors
preventable risk factors underlie most NCDs.
Most NCDs are strongly associated and causally
linked with four particular behaviours:
tobacco use,
physical inactivity,
unhealthy diet
harmful use of alcohol
Risk factors Lead to
four key metabolic/physiological changes:
raised blood pressure,
overweight/obesity,
hyperglycemia and
hyperlipidemia.
attributable deaths
leading NCD risk factor globally
raised blood pressure 13% of global deaths are
attributed),
tobacco use (9%),
raised blood glucose (6%),
physical inactivity (6%),
and overweight and obesity (5%)
Epidemiological Determinants
1. Insulin deficiency; complete or partial
Pancreatic disorders
Insulin synthesis abnormality
Destructions of beta cells
Autoimmune reaction
2. Insulin Resistance
Risk factors
Non- Modifiable Risk
factors
Age
Gender
Genetic factors
Ethnicity
Family History
Modifiable Risk
factors
Physical inactivity
Diet
High saturated fat intake,
salt intake
Low vegetables and fruits
intake
Low Dietary Fibre intake
Stress
Clinical features
Mostly Asymptomatic
Polydipsia, Polyuria and Polyphagia
Blood sugar testing
Fasting
Post-prandial – after a 75g glucose load
ICMR-WHO guidelines for management of Type 2 DM, 2005
Table 1: Values for Diagnosis
Fasting Random
Venous
Plasma
Glucose
= 7.0
mmol/L
( 126 mg/dl)
>= 11.1
mmol/L
> 200 mg/dl
Clinical Practice Guidelines (CPG) on Management of Type
2 Diabetes Mellitus (T2DM). (May 2009)
Diagnostic values for Type 2 Diabetes
Mellitus OGTT
Category 0-hour 2-hour
Normal < 6.1* (110 mg/dl) < 7.8 (140 mg dl)
IFG 6.1* – 6.9
(110 – 125mg dl)
-
IGT - 7.8 – 11.0 (140 –
199 mg dl)
DM >= 7.0 (126mg/dl) >=11.1 (200 mg dl)
Complications of DM
 Macrovascular
Coronary heart disease
Most common cause of death
50 to 80% of all the deaths due to Diabetes
Microvascular
Retinopathy
Nephropathy
Neuropathy
Foot ulcer Most common cause of disability
50% of non-traumatic amputations
Complications of DM
Primary Prevention
Healthy nutritional habits
Promotion of physical activity
Maintenance of ideal body weight
Create awareness on lifestyle modification
Enabling Environment
Screening- Target population
Asymptomatic (ICMR)
Age >= 30 yrs
Overweight BMI >23
Central Obesity: Waist
Hip Ratio men > 0.9
Women > ).85
Family History
Sedentary Lifestyle
Previous History IFG IGT
Gestational Diabetes
Large Baby >3.5 kg
Hypertension >140/90
Dyslipedemia
Screening High Risk
Family History
Symptoms of
Hyperglyceamia
Complications of
diabetes – tiredness,
burning feet, infections,
balanitis
Tuberculosis
Steroids
Polycystic Ovarian
Disease
Prematrue vascular
disease
Secondary Prevention
Self Care in diabetes
Identification card
Adherence to drugs and diet regimen
Periodic check ups
Foot care
No fasting and feasting
Follow up care
 3 monthly
6 monthly
Annually
FBG and PPBG
Clinical examination including BP and foot examination
Reinforce life style modifications and compliance to drug treatment
HbA1c
Blood urea and serum creatinine
Lipid profile
Urine: protein/albumin; micro albuminuria
Fundus examination
ECG
 Maintain ideal blood glucose level
a. Nonpharmacological treatment
Dietary modification
Promotion of physical activity
Avoid Tobacco and Alcohol
Stress Management
b. Drugs
Oral hypoglycemic agents
Insulin
Tertiary Prevention

Disability limitation and rehabilitation
Major cause of disability
Blindness
Renal failure
Gangrene of foot
Special clinics
Program for control of NCDs
National Program for control of CVD, Diabetes,
Cancer, Stroke (NPCDCS)
Age-standardized prevalence of overweight in
adults aged 20+ years
Age-standardized prevalence of obesity in
adults aged 20+ years
Classification of Obesity
In 2008, 35% of adults aged 20 years and older were
overweight (BMI ≥ 25 kg/m2) (34% men and 35% of
women).
Worldwide prevalence of obesity has nearly doubled
between 1980 and 2008.
In 2008, 10% of men and 14% of women in the world
were obese (BMI ≥30 kg/m2), compared with 5% for men
and 8% for women in 1980
An estimated 205 million men and 297 million women
over the age of 20 were obese in 2008 – a total of more
than half a billion adults worldwide
Targets for control f Diabetes
Epidemiology of diabetes mellitus

Epidemiology of diabetes mellitus

  • 1.
  • 2.
    Specific Learning Objectives Atthe end of the class the student should be able to: Enumerate the risk factors for Diabetes mellitus (DM) Diagnose DM based on blood sugar values List the preventive measures in accordance with the levels of prevention Enumerate the components of self-management in
  • 3.
    PLAN Definition and Classificationof Diabetes Burden of diabetes mellitus (Type 2) Epidemiological determinants Clinical features Prevention and control Summary
  • 4.
    Definition A metabolic disorderof multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both
  • 5.
    Classification  Type 1diabetes Lack of insulin Autoimmune Usually children Type 2 diabetes Insulin resistance Lifestyle factors Usually adults Gestational diabetes Insulin resistance During pregnancy Risks to mother and child Impaired Glucose tolerance (IGT) Malnutrition Related Diabetes (MRDM) Other Types Hormonal Drug Induced Genetic
  • 6.
    Prevalence of diabetesworldwide in 2000 (per 1000 inhabitants). World average was 28.23‰ no data less than 7.5 7.5-15 15-22.5 22.5-30 30-37.5 37.5-45 45-52.5 52.5-60 60-67.5 67.5-75 75-82.5 more than 82.5 http://en.wikipedia.org/wiki/File:Diabetes_world_map_-_2000.svg
  • 7.
    Worldwide Prevalence ofDiabetes 2000- 2030
  • 8.
  • 10.
    People with diabetesrequire at least two to three times the health-care resources compared to people who do not have diabetes care may account for up to 15% of national health care budgets risk of tuberculosis is three times higher among people with diabetes
  • 12.
  • 13.
    Proportion of Diabetesrelated deaths in people under 60 out of all dying due to diabetes
  • 14.
    Age-standardized prevalence ofdiabetes in adults aged 25+ years, by WHO Region and World Bank income group, comparable estimates, 2008 Chapter 1 – Burden: mortality, morbidity and risk factors. http://www.who.int/diabetes/facts/en/
  • 15.
    Estimated number ofdiabetic subjects in India. Epidemiology of type 2 diabetes: Indian scenario Indian J Med Res 125, March 2007, pp 217-230
  • 16.
    Projected increase indiabetes - India  Because of “Asian Indian Phenotype”  unique clinical and biochemical abnormalities in Indians  increased insulin resistance, greater abdominal adiposity  higher waist circumference despite lower BMI,  lower adiponectin and higher high sensitive C-reactive protein levels.
  • 17.
    Recent population basedstudies showings the prevalence of type 2 diabetes in different parts of India Epidemiology of type 2 diabetes: Indian scenario Indian J Med Res 125, March 2007, pp 217-230
  • 18.
    India vs worldprevalence of diabetes
  • 20.
    Indian Scenario Prevalence –8.6 % 66 million estimated cases 53% of these cases are undiagnosed 1/3rd of income spent on Diabetes in poorest households "Diabetes Capital of the World" Source: Diabetes Atlas, International Diabetes Federation 6th edition
  • 23.
    Secular trends inthe prevalence of impaired glucose tolerance (IGT) and diabetes at Chennai
  • 24.
    Age wise prevalenceof diabetes Chennai urban rural epidemiology study (CURES) vs National Urban Diabetes Survey (NUDS) [ref 39] Haat09i1p1.pdf
  • 25.
    Global Prevalence ofDiabetesDIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004
  • 26.
    Why This Scenario? primary driver - rapid epidemiological transition  associated with changes in dietary patterns  decreased physical activity  as evident from the higher prevalence of diabetes in the urban population  prevalence of microvascular complications retinopathy and nephropathy are comparatively lower in Indians,  prevalence of premature coronary artery disease is much higher in Indians compared to other ethnic groups.
  • 27.
    Risk factors preventable riskfactors underlie most NCDs. Most NCDs are strongly associated and causally linked with four particular behaviours: tobacco use, physical inactivity, unhealthy diet harmful use of alcohol
  • 28.
    Risk factors Leadto four key metabolic/physiological changes: raised blood pressure, overweight/obesity, hyperglycemia and hyperlipidemia.
  • 29.
    attributable deaths leading NCDrisk factor globally raised blood pressure 13% of global deaths are attributed), tobacco use (9%), raised blood glucose (6%), physical inactivity (6%), and overweight and obesity (5%)
  • 30.
    Epidemiological Determinants 1. Insulindeficiency; complete or partial Pancreatic disorders Insulin synthesis abnormality Destructions of beta cells Autoimmune reaction 2. Insulin Resistance
  • 31.
    Risk factors Non- ModifiableRisk factors Age Gender Genetic factors Ethnicity Family History Modifiable Risk factors Physical inactivity Diet High saturated fat intake, salt intake Low vegetables and fruits intake Low Dietary Fibre intake Stress
  • 32.
    Clinical features Mostly Asymptomatic Polydipsia,Polyuria and Polyphagia Blood sugar testing Fasting Post-prandial – after a 75g glucose load ICMR-WHO guidelines for management of Type 2 DM, 2005
  • 33.
    Table 1: Valuesfor Diagnosis Fasting Random Venous Plasma Glucose = 7.0 mmol/L ( 126 mg/dl) >= 11.1 mmol/L > 200 mg/dl Clinical Practice Guidelines (CPG) on Management of Type 2 Diabetes Mellitus (T2DM). (May 2009)
  • 34.
    Diagnostic values forType 2 Diabetes Mellitus OGTT Category 0-hour 2-hour Normal < 6.1* (110 mg/dl) < 7.8 (140 mg dl) IFG 6.1* – 6.9 (110 – 125mg dl) - IGT - 7.8 – 11.0 (140 – 199 mg dl) DM >= 7.0 (126mg/dl) >=11.1 (200 mg dl)
  • 35.
    Complications of DM Macrovascular Coronary heart disease Most common cause of death 50 to 80% of all the deaths due to Diabetes Microvascular Retinopathy Nephropathy Neuropathy Foot ulcer Most common cause of disability 50% of non-traumatic amputations Complications of DM
  • 36.
    Primary Prevention Healthy nutritionalhabits Promotion of physical activity Maintenance of ideal body weight Create awareness on lifestyle modification Enabling Environment
  • 37.
    Screening- Target population Asymptomatic(ICMR) Age >= 30 yrs Overweight BMI >23 Central Obesity: Waist Hip Ratio men > 0.9 Women > ).85 Family History Sedentary Lifestyle Previous History IFG IGT Gestational Diabetes Large Baby >3.5 kg Hypertension >140/90 Dyslipedemia
  • 38.
    Screening High Risk FamilyHistory Symptoms of Hyperglyceamia Complications of diabetes – tiredness, burning feet, infections, balanitis Tuberculosis Steroids Polycystic Ovarian Disease Prematrue vascular disease
  • 39.
    Secondary Prevention Self Carein diabetes Identification card Adherence to drugs and diet regimen Periodic check ups Foot care No fasting and feasting
  • 40.
    Follow up care 3 monthly 6 monthly Annually FBG and PPBG Clinical examination including BP and foot examination Reinforce life style modifications and compliance to drug treatment HbA1c Blood urea and serum creatinine Lipid profile Urine: protein/albumin; micro albuminuria Fundus examination ECG
  • 41.
     Maintain idealblood glucose level a. Nonpharmacological treatment Dietary modification Promotion of physical activity Avoid Tobacco and Alcohol Stress Management b. Drugs Oral hypoglycemic agents Insulin
  • 42.
    Tertiary Prevention  Disability limitationand rehabilitation Major cause of disability Blindness Renal failure Gangrene of foot Special clinics
  • 43.
    Program for controlof NCDs National Program for control of CVD, Diabetes, Cancer, Stroke (NPCDCS)
  • 44.
    Age-standardized prevalence ofoverweight in adults aged 20+ years
  • 45.
    Age-standardized prevalence ofobesity in adults aged 20+ years
  • 46.
  • 48.
    In 2008, 35%of adults aged 20 years and older were overweight (BMI ≥ 25 kg/m2) (34% men and 35% of women). Worldwide prevalence of obesity has nearly doubled between 1980 and 2008. In 2008, 10% of men and 14% of women in the world were obese (BMI ≥30 kg/m2), compared with 5% for men and 8% for women in 1980 An estimated 205 million men and 297 million women over the age of 20 were obese in 2008 – a total of more than half a billion adults worldwide
  • 49.